<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        31-968-17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ANNUVA 50 mg Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAMMAM PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAMMAM PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1898]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            DAMMAM PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAMMAM PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac free acid, the active ingredient in Annuva Tablets, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation.</p><p>Annuva Tablets act quickly and so are used to treat short term painful conditions affecting the joints and muscles.</p><p>&bull; Annuva tablets relieve pain, reduce swelling and ease inflammation in conditions affecting the joints, muscles and tendons including:</p><p>Rheumatoid arthritis, osteoarthritis, acute gout, ankylosing spondylitis, backache, sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations and fractures, tendonitis, tenosynovitis, bursitis.</p><p>&bull; They are also used to treat pain and inflammation associated with dental and minor surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not take Annuva if</strong></p><p>&bull; You think you may be allergic to diclofenac free acid, aspirin, ibuprofen or any other NSAID, or to any of the other ingredients of Annuva Tablets. (These are listed at the end of the leaflet.) Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reaction</p><p>&bull; You have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces)</p><p>&bull; You have had stomach or bowel problems after you have taken other NSAIDs</p><p>&bull; You have severe heart, kidney or liver failure</p><p>&bull; You are more than six months pregnant.</p><p>&bull; You have ischemic heart disease</p><p>&bull; You have peripheral arterial disease</p><p>&bull; You have cerebrovascular disease</p><p>&bull;You have congestive heart failure (New York Heart Association [NYHA] classification II &ndash; IV</p><p><strong>&nbsp;</strong></p><p><strong>b. Take special care with Annuva</strong></p><p>&bull; If you suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&#39;s disease</p><p>&bull; If you have kidney or liver problems, or are you elderly</p><p>&bull; If you have a condition called porphyria</p><p>&bull; If you suffer from any blood or bleeding disorder, your doctor may ask you to go for regular check-ups while you are taking these tablets.</p><p>&bull; If you have ever had asthma</p><p>&bull; If you are breast-feeding</p><p>&bull; If you have heart problems, or have you had a stroke, or do you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker)</p><p>&bull; If you have Lupus (SLE) or any similar condition</p><p>Diclofenac treatment should only be initiated after careful consideration for patients with significant risk factors for cardiovascular events (e.g., Hypertension, Hyperlipidemia, diabetes mellitus, and smoking).</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&rsquo;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>&nbsp;</p><p>In post marketing reports, cases of drug-induced hepatotoxicity have been reported in the first month, and in some cases, but can occur at any time during treatment with diclofenac. Post marketing surveillance has reported cases of severe hepatic reactions, including liver necrosis, jaundice, hepatitis with and without jaundice, and liver failure. Some of these reported cases resulted in fatalities or liver transplantation.</p><p>Physicians should measure liver enzymes especially transaminases periodically in patients receiving long-term therapy with diclofenac during week 4 &ndash; 8 from starting of treatment.</p><p>&nbsp;</p><p><strong>Cardiovascular Risk:</strong></p><ul><li>NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.</li><li>All dosage forms of Diclofenac are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.</li></ul><p><strong>Gastrointestinal Risk:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>NSAIDs cause an increased risk of serious gastrointestinal adverse events including inflammation bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>c. Taking other medicines, herbal or dietary supplements</strong><strong> </strong></p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are taking any of the following:</p><p>&bull; Medicines to treat diabetes.</p><p>&bull; Anticoagulants (blood thinning tablets like warfarin).</p><p>&bull; Diuretics (water tablets) various NSAIDs are liable to inhibit the activity of diuretics.</p><p>&bull; Lithium (used to treat some mental problems) Annuva may increase plasma level of concurrently administered of Lithium.</p><p>&bull; Methotrexate (for some inflammatory diseases and some cancers).</p><p>&bull; Ciclosporin or tacrolimus (used to treat some inflammatory diseases and after transplants).</p><p>&bull; Quinolone antibiotics (for infections).</p><p>&bull; Any other NSAID for example aspirin or ibuprofen or COX-2 (cyclo-oxgenase-2) inhibitor.</p><p>&bull; Mifepristone (a medicine used to terminate pregnancy)</p><p>&bull; Cardiac glycosides (for example digoxin), used to treat heart problems.</p><p>&bull; Medicines known as SSRIs used to treat depression</p><p>&bull; Oral steroids (an anti-inflammatory drug)</p><p>&bull; Medicines used to treat heart conditions or high blood pressure, for example betablockers or ACE inhibitors.</p><p>&bull; Sulfinpyrazone (a medicine used to treat gout) or voriconazole (a medicine used to treat fungal infections).</p><p>&bull; Phenytoin (a medicine used to treat seizures)</p><p>&bull; Colestipol/cholestyramine (used to lower cholesterol)</p><p>Always tell your doctor or pharmacist about all the medicines you are taking.</p><p>This means medicines you have bought yourself as well as medicines on prescription from your doctor.</p><p><strong>e.</strong> <strong>Pregnancy and Lactation</strong></p><p>&bull; Are you pregnant or planning to become pregnant? Although not common, abnormalities have been reported in babies whose mothers have taken NSAIDs during pregnancy.</p><p>You should not take Annuva Tablets during the last 3 months of pregnancy as it may affect the baby&rsquo;s circulation.</p><p>&bull; Are you trying for a baby? Taking Annuva Tablets may make it more difficult to conceive. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</p><p><strong>f. Driving and using machines</strong></p><p>Very occasionally people have reported that Annuva Tablets have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p><strong>Other special warnings</strong></p><p>&bull; You should take the lowest dose of Annuva Tablets for the shortest possible time, particularly if you are underweight or elderly.</p><p>&bull; There is a small increased risk of heart attack or stroke when you are taking any medicine like Annuva. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</p><p>&bull; Whilst you are taking these medicines your doctor may want to give you a check-up from time to time.</p><p>&bull; If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</p><p>&bull; Because it is an anti-inflammatory medicine, Annuva Tablets may reduce the symptoms of infection, for example headache, and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking Annuva Tablets.</p><p>&bull; Annuva Tablets are not suitable for children.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor will tell you how many Annuva Tablets to take and when to take them. Always follow his/her instructions carefully.</p><p>If you are not sure, ask your doctor or pharmacist. Keep taking your tablets for as long as you have been told, unless you have any problems. In that case, check with your doctor.</p><p><strong>Taking Annuva with food and drink</strong></p><p>Take the tablets before or with food.</p><p>Drop the tablets into a glass of water, and stir. Drink at once. To make sure you get all of the medicine, rinse the glass round with a small amount of water and drink this as well.</p><p><strong>The usual doses are:</strong></p><p><strong>Adults</strong></p><p>One tablet two or three times a day.</p><p><strong>Elderly</strong></p><p>Your doctor may advise you to take a dose that is lower than the usual adult dose if you are elderly. Your doctor may also want to check closely that the Annuva Tablets are not affecting your stomach.</p><p><strong>These tablets are not suitable for children.</strong></p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well.</p><p><strong>What if you forget to take a dose?</strong></p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, though, just take the next dose and forget about the one you missed. Do not double up on the next dose to make up for the one missed. Do not take more than 150 mg (three tablets) in 24 hours.</p><p><strong>What if you take too many tablets?</strong></p><p>If you, or anyone else, accidentally take too much, tell your doctor or your nearest hospital casualty department. Take your medicine pack with you so that people can see what you have taken.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Annuva Tablets are suitable for most people, but, like all medicines, they can sometimes cause side effects.</p><p><strong>Some side effects can be serious</strong></p><p><strong>Stop taking Annuva Tablets and tell your doctor straight away if you notice:</strong></p><p>&bull; Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick)</p><p>&bull; Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black, tarry faeces</p><p>&bull; Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering</p><p>&bull; Wheezing or shortness of breath (bronchospasm)</p><p>&bull; Swollen face, lips, hands or fingers</p><p>&bull; Yellowing of your skin or the whites of your eyes</p><p>&bull; Persistent sore throat or high temperature</p><p>&bull; An unexpected change in the amount of urine produced and/or its appearance.</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or</p><p>Infections, tell your doctor.</p><p><strong>The side effects listed below have also been reported.</strong></p><p><strong>Common side effects (These may affect between 1 and 10 in every 100 patients):</strong></p><p>&bull; Stomach pain, heartburn, nausea, vomiting, diarrhea, indigestion, wind, loss of appetite</p><p>&bull; Headache, dizziness, vertigo</p><p>&bull; Skin rash or spots</p><p>&bull; Raised levels of liver enzymes in the blood</p><p><strong>Rare side effects (These may affect between 1 in every 1000 to 1 in every 10,000 patients):</strong></p><p>&bull; Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly)</p><p>&bull; Gastritis (inflammation, irritation or swelling of the stomach lining)</p><p>&bull; Vomiting blood</p><p>&bull; Diarrhea with blood in it or bleeding from the back passage</p><p>&bull; Black, tarry feces or stools</p><p>&bull; Drowsiness, tiredness</p><p>&bull; Hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness)</p><p>&bull; Skin rash and itching</p><p>&bull; Fluid retention, symptoms of which include swollen ankles</p><p>&bull; Liver function disorders, including hepatitis and jaundice</p><p><strong>Very Rare side effects (These may affect less than 1 in every 10,000 patients):</strong></p><p><strong>Effects on the nervous system:</strong></p><p>Tingling or numbness in the fingers, tremor, visual disturbances such as blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental disorders, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck, disturbances in sensation.</p><p><strong>Effects on the stomach and digestive system:</strong></p><p>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or lips, taste changes, lower gut disorders (including inflammation of the colon, or worsening of ulcerative colitis or Crohn&rsquo;s disease).</p><p><strong>Effects on the heart, chest or blood:</strong></p><p>Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood pressure), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), heart disorders, including congestive heart failure or heart attack, blood disorders (including anemia), stroke.</p><p><strong>Effects on the liver or kidneys:</strong></p><p>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine.</p><p><strong>Effects on skin or hair:</strong></p><p>Serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight.</p><p><strong>Hair loss.</strong></p><p><strong>Other side effects that have also been reported include:</strong></p><p>Inflammation of the pancreas, impotence. Facial swelling, inflammation of the lining of the brain (meningitis), stroke, throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye.</p><p>Do not be alarmed by this list - most people take Annuva Tablets without any problems.</p><p>If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store in a dry place, below 25&deg;C.</p><p>Keep out of the reach and sight of children.</p><p>Do not take Annuva Tablets after the expiry date which is printed on the outside of the pack.</p><p>If your doctor tells you to stop taking the tablets, please take any unused tablets back to your pharmacist to be destroyed. Do not throw them away with your normal household water or waste. This will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Annuva dispersible tablets contain 46.5 mg of diclofenac free acid as an active ingredient equivalent to 50 mg of diclofenac sodium.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                A white to off-white square, flat bevelled edge uncoated tablet engraved with "T130" on one side and plain on the other side.
The tablets also contain the inactive ingredients
Lact/Cellul-Cellactose (Meggle),Kollidon CL BASF, Colloidal Silicon Dioxide, Sodium Lauryl Sulphate
 Each pack contains 20 dispersible tablets

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dammam Pharma</strong></p><p>Dammam Pharmaceutical Plant</p><p>Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December 2017.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">دايكلوفيناك حمض(المادة الفعالة في أنوفا) تنتمي لمجموعة من الأدوية تسمى مضادات الالتهابات غير ستيرويدى وهى تستخدم في تقليل الألم والالتهاب.</p><p dir="RTL">يعمل أنوفا بشكل سريع ولذلك فهو يستخدم كعلاج للألم قصير الأجل الذي يؤثر على المفاصل و العضلات.</p><p dir="RTL">أنوفا يسكن الألم و يقلل التورم و الالتهابات في الحالات التي تؤثر في المفاصل والعضلات و الأوتار والتي تشمل:</p><p dir="RTL">التهاب المفاصل الروماتويدى و التهاب المفاصل المفصلي و النقرس الحاد و التهاب الفقرات وآلام الظهر و الالتواء و إصابات الأنسجة الرخوة الناتجة عن ممارسة الرياضة و تيبس الكتف وحالات الخلع والكسر و التهاب الأوتار والتهاب غمد الأوتار و الالتهاب الكيسي.</p><p dir="RTL">كما يستخدم أيضا في علاج حالات ألم والتهاب الأسنان والعمليات الجراحية الصغيرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>امتنع عن تناول أنوفا في الحالات الآتية:</strong></p><p dir="RTL">&nbsp;&bull;إذا كنت تعتقد أنه لديك حساسية ل دايكلوفيناك حمض أو أسبيرين أو إيبوبروفين أو أي دواء مضاد للالتهابات غير ستيرويدى آخر أو لأي من المكونات الأخرى ل أنوفا (والمذكورة في آخر هذه النشرة).أعراض فرط التحسس هي تورم الوجه و الفم ومشاكل في التنفس و سيلان الأنف و طفح جلدي أو أي نوع آخر من أنواع تفاعلات الحساسية.</p><p dir="RTL">&bull; إذا كنت تعانى أو عانيت من قرحة في المعدة أو الاثنى عشر أو نزيف في الجهاز الهضمي (وهو قد يسبب وجود دم في القيء أو نزيف أثناء إفراغ الأمعاء أو وجود دم في البراز أو تغير لون البراز إلى اللون الأسود القطرانى)</p><p dir="RTL">&bull; إذا تعرضت لمشاكل في المعدة أو الأمعاء بعد تناولك لدواء مضاد للالتهابات غير ستيرويدى آخر.</p><p dir="RTL">&bull; إذا كنت تعانى من مشاكل حادة في القلب أو الكلية أو فشل كبدي.</p><p dir="RTL">&bull; إذا كنت حامل في فترة ما بعد الشهر السادس.</p><p dir="RTL">&bull; مرض القلب الإقفاري</p><p dir="RTL">&bull; مرض الشرايين الطرفية</p><p dir="RTL">&bull; أمراض الأوعية الدماغية</p><p dir="RTL">&bull; فشل القلب الإحتقاني (جمعية القلب بنيويورك [NYHA] تصنيف (IV &ndash; II).</p><p dir="RTL"><strong>ينبغي توخي الحذر عند تناول أنوفا:</strong></p><p dir="RTL">&bull; إذا كنت تعانى من أي أمراض في المعدة أو الأمعاء بما في ذلك التهاب القولون التقرحي أو مرض كروهن</p><p dir="RTL">&bull; إذا كنت تعانى من مشاكل في الكلية أو الكبد أو إذا كنت من كبار السن</p><p dir="RTL">&bull; إذا كان لديك حالة من حالات البورفيريا</p><p dir="RTL">&bull; إذا كنت تعانى من أي مشاكل في الدم أو مشاكل متعلقة بالنزيف ولذلك قد يطلب منك الطبيب أن تقوم بعمل فحوصات دورية أثناء تناولك لهذا الدواء</p><p dir="RTL">&bull; إذا كنت تعانى في أي وقت من الأوقات من الربو</p><p dir="RTL">&bull; إذا كنت تقومين بإرضاع طفلك رضاعة طبيعية</p><p dir="RTL">&bull; إذا كنت تعانى من مشاكل في القلب أو تعرضت للسكتة الدماغية أو إذا كنت تعتقد أنك في خطر من هذه الأمراض (مثل إذا كنت تعانى من ارتفاع في ضغط الدم أو السكر أو الكوليستيرول أو إذا كنت مدخنا)</p><p dir="RTL">&bull; إذا كنت تعانى من مرض الذئبة أو أي حالة مشابهة</p><p dir="RTL">ينبغي أن تبدأ العلاج بدايكلوفيناك بعد دراسة متأنية للمرضى من عوامل الخطر الهامة لأحداث القلب والأوعية الدموية (على سبيل المثال، ارتفاع ضغط الدم، الدهون، وداء السكري، والتدخين).</p><p dir="RTL">قد تزيد مخاطر القلب والأوعية الدموية من دايكلوفيناك مع جرعة ومدة التعرض، لذلك ينبغي استخدامه لأقصر مدة ممكنة وبأقل جرعة يومية فعالة. يجب أن يعاد تقييم حاجة المريض لتخفيف الأعراض واستجابة المريض للعلاج دوريا.</p><p dir="RTL">بناء على تقارير ما بعد التسويق و التي ذكرت حدوث حالات من التسمم الكبدي المرتبط باستخدام الدواء (و التي تظهر خلال الشهر الأول من الاستخدام أو خلال أي فترة أخرى) ومنها تفاعلات كبدية حادة مثل نخر كبدي , يرقان , التهاب كبد مع أو بدون يرقان , أو فشل كبدي كما أن بعض هذه الحالات قد أفضى إلى الوفاة أو الحاجة لنقل و زراعة الكبد.</p><p dir="RTL">ينبغي على الممارسين الصحيين الفحص الدوري لإنزيمات الكبد خاصة إنزيمات Transaminases للمرضى على أن تبدأ الاختبارات و التحاليل خلال فترة 4 &ndash; 8 أسابيع من بدء العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>احتمالات الخطورة علي</strong><strong> الجهاز الدوري</strong><strong> :</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><ul><li dir="RTL">من المحتمل أن تؤدى جميع&nbsp; مضادات الالتهابات غير الستيرويدية إلي زيادة معدل الخطورة بالنسبة لزيادة التخثر بالدم، الإحتشاء القلبي، والصدمة الدماغية. هذه الحالات السابقة قد تكون مميتة. ويزيد معدل الخطورة مع زيادة مدة الاستعمال لهذه المستحضرات. مرضي الجهاز الدوري أو الذين يزيد لديهم احتمالية الإصابة بأمراض الجهاز الدوري، هم أكثر تعرضاً للإصابة بالحالات السابق ذكرها.</li><li dir="RTL">يمنع استخدام كل أشكال الدايكلوفيناك في علاج حالات الألم المتعلقة بجراحات الشريان التاجي (عمليات التحويل التاجية الإكليلية، ترقيع الشريان التاجي) قبل وأثناء وبعد العملية.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>احتمالات الخطورة علي</strong><strong> الجهاز الهضمي</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">تؤدى جميع مضادات الالتهاب غير الستيرويدية إلي زيادة معدل خطورة الإصابة بمضاعفات في الجهاز الهضمي من بينها الالتهابات، النزيف والقرحة وثقب في المعدة وفى الأمعاء الدقيقة والتي قد تكون مميتة.</p><p dir="RTL">يمكن أن تحدث هذه المضاعفات في أي وقت أثناء الاستخدام وبدون أي علامات تحذير مسبقة.</p><p dir="RTL">يعد المرضي من كبار السن هم الأكثر عرضة للآثار السابق ذكرها علي الجهاز الهضمي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">بعض الأدوية قد تتعارض مع هذا الدواء فضلا اخبر طبيبك أو الصيدلي إذا كنت تأخذ أي من الأدوية التالية:</p><p dir="RTL">&bull; الأدوية التي تستخدم في علاج داء السكرى .</p><p dir="RTL">&nbsp;&bull; الأدوية المضادة للتجلط (الأدوية التي تزيد سيولة الدم مثل وارفارين).<strong> </strong></p><p dir="RTL">&bull; مدرات البول.</p><p dir="RTL">&bull; الليثيوم (يستخدم لعلاج بعض الأمراض العقلية).</p><p dir="RTL">&bull; ميثوتريكسات (يستخدم لعلاج بعض أمراض الالتهابات و بعض أمراض السرطان).</p><p dir="RTL">&bull; سيكلوسبورين أو تاكروليميس (يستخدم لعلاج بعض أمراض الالتهابات وبعد زراعة الأعضاء).</p><p dir="RTL">&nbsp;&bull; كينولون (مضادات حيوية تستخدم لعلاج العدوى).</p><p dir="RTL">&bull; أي دواء مضاد للالتهابات غير ستيرويدى أخر (مثل: أسبيرين أو إيبوبروفين)&nbsp; أو مضاد لإنزيم كوكس - II</p><p dir="RTL">&bull; ميفيبريستون (دواء يستخدم لإنهاء الحمل)</p><p dir="RTL">&bull; الجليكوسايد القلبية (مثل: ديجوكسين الذي يستخدم لعلاج مشاكل القلب).</p><p dir="RTL">&bull; الأدوية المعروفة ب مضادات امتصاص السيروتونين والتي تستخدم لعلاج الاكتئاب.</p><p dir="RTL">&bull; الستيرويد التي تستخدم عن طريق الفم والتي تستخدم لعلاج الالتهابات</p><p dir="RTL">&bull; الأدوية التي تستخدم لعلاج مشاكل القلب أو ارتفاع ضغط الدم مثل الأدوية التي تغلق مستقبلات بيتا أو تثبط عمل&nbsp; الانزيم المحول لانجيوتنسين</p><p dir="RTL">&bull; سلفيبيرازون (علاج للنقرس) أو فوريكونازول (علاج العدوى الفطرية)</p><p dir="RTL">&bull; فينيتوين (علاج للنوبات التشنجية)</p><p dir="RTL">&bull; كولستيبول/ كوليستيرامين (لتقليل الكوليستيرول)</p><p dir="RTL">لذلك دائما أخبر طبيبك بالأدوية التي تتناولها بما في ذلك الأدوية التي وصفها لك طبيب آخر أو حتى الأدوية التي حصلت عليها بدون وصفة طبية</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنت حامل لا تتناولي أنوفا في آخر 3 شهور في الحمل لأن ذلك قد يؤثر على الدورة الدموية لطفلك حتى مع عدم شيوع حدوث تشوهات في الأطفال التي تستخدم أمهاتهم أدوية مضادة للالتهابات غير ستيرويدى.</p><p dir="RTL">إذا كنت تخططي للحمل، تناولك ل أنوفا قد يجعل الحمل صعبا ولذلك يجب أن تخبرى طبيبك أنك تخططين للحمل أو أنك تواجهين مشاكل في حدوث الحمل</p><p dir="RTL"><strong>القيادة واستخدام</strong><strong> الآلات</strong></p><p dir="RTL">في بعض الأحيان يوجد بعض الحالات التي جعل فيها أنوفا المرضى يشعرون بالدوار أوالتعب أو النعاس أو مشاكل في رؤية العين لذلك إذا شعرت بأى من هذه الأعراض لا تقود أو تستخدم الآلات</p><p dir="RTL"><strong>تحذيرات أخرى:</strong></p><p dir="RTL">&bull; ينبغي أن تتناول أقل جرعة من أقراص أنوفا لأقل وقت ممكن خصوصا إذا كنت تحت الوزن المطلوب أو إذا كنت من كبار السن</p><p dir="RTL">&bull; يوجد زيادة قليلة في خطورة حدوث أزمة قلبية أو سكتة دماغية عند تناول أدوية مثل أنوفا وتزيد الخطورة بزيادة الجرعة و مدة العلاج لفترة طويلة لذلك يجب اتباع نصائح طبيبك عن جرعة و مدة العلاج</p><p dir="RTL">&bull; قد يطلب منك طبيبك عمل فحوص دورية من وقت إلى آخر عند تناولك لهذا العلاج</p><p dir="RTL">&bull; إذا كان لديك تاريخ مرضى لمشاكل في المعدة عند تناولك الأدوية المضادة للالتهابات غير الستيرويدى خصوصا إذا كنت من كبار السن اخبر طبيبك فورا إذا لاحظت أي أعراض غير معتادة</p><p dir="RTL">&bull; لأن أنوفا دواء مضاد للالتهاب فهو قد يقلل أعراض العدوى مثل الصداع وارتفاع درجة الحرارة ولذلك إذا شعرت بالمرض أو الحاجة لزيارة الطبيب اخبر طبيبك أنك تتناول أنوفا</p><p dir="RTL">&bull; أقراص أنوفا لا تناسب الأطفال</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سوف يخبرك الطبيب عن عدد أقراص أنوفا التي تتناولها ومتى تتناولها. اتبع تعليمات طبيبك بعناية.</p><p dir="RTL">إذا كنت غير متأكد اسأل طبيبك أو الصيدلي واستخدم أنوفا للمدة التي أخبرك الطبيب بها إلا إذا واجهتك أي مشاكل. في هذه الحالة راجع طبيبك.</p><p dir="RTL"><strong>تناول أنوفا مع الطعام والشراب</strong></p><p dir="RTL">تناول الأقراص قبل أو مع الأكل.</p><p dir="RTL">ضع القرص في كوب من الماء ورجه ثم اشربه في الحال. ولضمان تناول كل كمية الدواء اغسل الكوب بقليل من الماء ثم اشربه أيضا.</p><p dir="RTL">الجرعات المعتادة هي:</p><p dir="RTL">البالغين:</p><p dir="RTL">قرص واحد مرتين أو ثلاث مرات في اليوم</p><p dir="RTL">كبار السن:</p><p dir="RTL">سوف يقوم الطبيب بإخبارك عن كيفية تناول الدواء بجرعة أقل من الجرعة المعتادة إذا كنت من كبار السن كما قد يطلب الطبيب فحصك بدقة كي يتأكد الطبيب أن أنوفا لا يؤثر على معدتك.</p><p dir="RTL">هذه الأقراص لا تناسب الأطفال</p><p dir="RTL">قد يصف لك الطبيب دواء آخر يتم تناوله في نفس الوقت ليحمى المعدة خصوصا إذا كنت عانيت من مشاكل في المعدة من قبل أو إذا كنت من كبار السن أو إذا كنت تأخذ أدوية معينه.</p><p dir="RTL"><strong>إذا نسيت تناول جرعة أنوفا </strong></p><p dir="RTL">إذا نسيت تناول جرعة من أنوفا تناولها عندما تتذكر أما إذا كان الوقت قريب جدا من الجرعة التالية تناول الجرعة التالية في وقتها و لا تأخذ الجرعتين لتعويض الجرعة المنسية ولا تأخذ أكثر من 150 ملجم (3 أقراص) في اليوم بأي حال من الأحوال.</p><p dir="RTL">إذا تناولت العديد من أقراص أنوفا</p><p dir="RTL">إذا تناولت أنت أو أي شخص بصورة عرضية العديد من الأقراص أخبر الطبيب أو توجه إلى أقرب مستشفى وخذ معك علبة الدواء حتى يعرفوا الدواء الذي تناولته.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص أنوفا مناسبة لمعظم المرضى ولكنه مثل جميع الأدوية قد يسبب بعض الأعراض الجانبية</p><p dir="RTL">بعض الأعراض الجانبية قد تكون خطيرة.</p><p dir="RTL"><strong>توقف عن تناول أنوفا واخبر طبيبك فورا إذا لاحظت أي من الأعراض الجانبية التالية:</strong></p><p dir="RTL">&bull; ألم في المعدة أو سوء هضم أو حموضة أو غازات أو غثيان أو قيئ</p><p dir="RTL">&bull; أي دلائل على وجود نزيف في المعدة أو الأمعاء مثل نزيف عند إفراغ الأمعاء أو وجود دم في القيء أو تحول لون البراز إلى اللون الأسود القطرانى</p><p dir="RTL">&bull; تفاعلات حساسية والتي تشمل طفح جلدي أو حكه أو كدمات أو وجود مناطق حمراء مؤلمة أو تقشر الجلد</p><p dir="RTL">&bull; صفير أو قصر في النفس (تشنج قصبي)</p><p dir="RTL">&bull; تورم الوجه والشفاه والأيدي و الأصابع</p><p dir="RTL">&bull; اصفرار الجلد أو اصفرار بياض العينين</p><p dir="RTL">&bull; احتقان مستمر في الحلق أو ارتفاع في درجة الحرارة</p><p dir="RTL">&bull; تغير غير متوقع في كمية البول مع أو بدون تغير مظهره</p><p dir="RTL">إذا لاحظت أنك أكثر عرضه للكدمات أو احتقان في الحلق أو العدوى من المعتاد اخبر طبيبك</p><p dir="RTL">الأعراض الجانبية التي تم رصدها&nbsp;</p><p dir="RTL"><strong>أعراض جانبية شائعة (قد تؤثر في من 1 إلى 10 في كل 100 مريض):</strong></p><p dir="RTL">&bull; ألم في المعدة أو حموضة أو غثيان أو قيئ أو إسهال أو سوء هضم أو غازات أو فقدان في الشهية</p><p dir="RTL">&bull; صداع أو دوار أو دوخه</p><p dir="RTL">&bull; طفح جلدي أو بقع جلدية</p><p dir="RTL">&bull; ارتفاع في مستوي إنزيمات الكبد في الدم</p><p dir="RTL"><strong>أعراض جانبية نادرة (قد تؤثر في 1 من كل 1000 إلى 1 من كل 10000 مريض):</strong></p><p dir="RTL">&bull; قرحه أو نزيف في المعدة (تم رصد حالات نادرة جدا سببت الموت خاصة من كبار السن)</p><p dir="RTL">&bull; التهاب في المعدة (التهاب أو تهيج أو تورم في الغشاء المبطن للمعدة)</p><p dir="RTL">&bull; وجود دم في القيء</p><p dir="RTL">&bull; إسهال مع وجود دم أو نزيف من المؤخرة</p><p dir="RTL">&bull; براز بلون أسود قطراني</p><p dir="RTL">&bull; نعاس أو تعب أو إرهاق</p><p dir="RTL">&bull; انخفاض ضغط الدم (وأعراضه إغماء أو دوار أو صداع)</p><p dir="RTL">&bull; طفح جلدي و حكه</p><p dir="RTL">&bull; احتباس السوائل وأعراضه تورم الكاحلين</p><p dir="RTL">&bull; اضطراب في وظائف الكبد بما في ذلك التهاب الكبد و الصفراء</p><p dir="RTL"><strong>أعراض جانبية نادرة جدا (قد تؤثر في أقل من 1 في كل 10000 مريض):</strong></p><p dir="RTL"><strong>تتعلق بالجهاز العصبي:</strong></p><p dir="RTL">وخز أو تنميل في الأصابع أو رعشة أو اضطراب في الرؤية مثل عدم وضوح الرؤية أو ثنائية الرؤية أو فقد أو اضطراب السمع أو طنين (صوت أجراس في الأذن) و عدم القدرة على النوم أو كوابيس أو تقلبات مزاجية أو اكتئاب أو قلق أو اضطرابات عقلية أو الضياع أو فقد الذاكرة أو تشنجات أو صداع مع كره الضوء الساطع أو حمى أو تصلب الرقبة أو اضطرابات في الإحساس</p><p dir="RTL"><strong>تتعلق بالمعدة و الجهاز الهضمي :</strong></p><p dir="RTL">إمساك و التهاب في اللسان أو تقرحات في الفم أو التهابات في داخل الفم و الشفاه أو تغييرات في الإحساس بالطعم أو اضطرابات في الجهاز الهضمي السفلى (بما في ذلك التهاب في القولون أو ازدياد حالة قرحة القولون سوءا أو مرض كروهن)</p><p dir="RTL"><strong>تتعلق بالقلب و الصدر والدم :</strong></p><p dir="RTL">خفقان (سرعة وعدم انتظام ضربات القلب) أو ألم في الصدر أو ارتفاع ضغط الدم أو التهاب في الأوعية الدموية أو التهاب في الرئة أو اضطرابات في القلب بما في ذلك فشل القلب الاحتقانى أو نوبات القلب أو اضطرابات في الدم (مثل الأنيميا) و السكتة الدماغية</p><p dir="RTL"><strong>تتعلق بالكبد و الكلى :</strong></p><p dir="RTL">اضطرابات حادة في الكلى أو الكبد بما في ذلك الفشل الكبدي و وجود دم أو بروتين في البول</p><p dir="RTL"><strong>تتعلق بالجلد أو الشعر :</strong></p><p dir="RTL">طفح جلدي حاد بما في ذلك ظاهرة ستيفينز جونسون و ظاهرة لايل و أنواع أخرى من الطفح الجلدي والتي قد تسوء بالتعرض لضوء الشمس</p><p dir="RTL">فقد الشعر</p><p dir="RTL"><strong>أعراض جانبية أخرى تم رصدها</strong></p><p dir="RTL">التهاب في البنكرياس أو العجز الجنسي أو تورم في الوجه أو التهاب سحائي أو سكتة دماغية أو اضطرابات في الحلق أو ارتباك أو هلوسة أو شعور عام بالتعب أو التهاب في أعصاب العين</p><p dir="RTL"><strong>لا تقلق من هذه القائمة من الأعراض الجانبية لأن معظم المرضى يتناولون أنوفا بدون أي مشاكل.</strong></p><p dir="RTL"><strong>إذا زادت أي من هذه الأعراض أو إذا لاحظت أعراض أخرى غير المذكورة هنا استشر طبيبك فربما يصف لك دواء آخر.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ في مكان جاف في درجة حرارة أقل من 25 &deg; مئوية.</p><p dir="RTL">يحفظ بعيد عن متناول ورؤية الأطفال</p><p dir="RTL">لا تتناول أقراص أنوفا بعد تاريخ الصلاحية الموجود على العبوة.</p><p dir="RTL">إذا أخبرك طبيبك أن تتوقف عن تناول أقراص أنوفا فضلا خذ الأقراص الغير مستخدمة للصيدلي ليتخلص منها. لا تتخلص منها في النفايات المنزلية أو الماء. ذلك سوف يساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي أقراص أنوفا القابلة للإنتشار على 46.5 مجم من المادة الفعالة وهي حمض دايكلوفيناك &nbsp;يعادل 50 مجم دايكلوفيناك صوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">أقراص مربعة لونها من أبيض إلى أبيض مطفي مسطحة مشطوفة الحواف غير مغطاة محفورة ب &ldquo;T130&rdquo; على جانب واحد وخالية من العلامات على الجانب الأخر.</p><p dir="RTL" style="text-align:right">تحتوى الأقراص أيضا على مواد غير فعالة وهى:</p><p dir="RTL" style="text-align:right">لاكت سيلول سيلاكتوز (ميجيل) و كوليدون و سيليكون ثنائى الأوكسيد الغروانى و صوديوم لوريل سلفات</p><p style="text-align:right">تحتوي كل عبوة على 20 قرص قابل للإنتشار.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>الدمام فارما</strong></p><p>مصنع الأدوية بالدمام</p><p>المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ديسيمبر 2017.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Annuva®Dispersible Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is (diclofenac). 
Each tablet contains 46.5mg of Diclofenac, which is equivalent to 50mg of diclofenac sodium. 
For a full list of excipients, see section 6.1. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dispersible Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR"><em>Adults and Elderly</em>:</p><p dir="LTR">The rapid onset of absorption of diclofenac from Annuva makes this preparation more suitable for <u>short-term</u> use in acute conditions for which treatment is required for no more than 3 months including: acute episodes of arthritic conditions, acute musculo-skeletal disorders and acute pain resulting from trauma.</p><p dir="LTR">There is no information on the use of Annuva for more than 3 months.</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use).</p><p>For oral administration</p><p><em>Adults</em>:</p><p>100-150mg daily in two or three divided doses. The Annuva tablet should be dropped into a glass of water, and the liquid stirred to aid dispersion, before swallowing.</p><p>The recommended maximum daily dose of Annuva is 150mg.</p><p><em>Children</em>: Not recommended.</p><p><em>Elderly</em>: Although the pharmacokinetics of Annuva are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions. In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also precautions) and the patient should be monitored for GI bleeding during NSAID therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or any of the excipients. 
• Active, or gastric or intestinal ulcer, bleeding or perforation. 
• History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy 
• Active, or history of recurrent peptic ulcer/hemorrhage (two or more distinct episodes of proven ulceration or bleeding) 
• Last trimester of pregnancy (see section 4.6 Pregnancy and lactation) 
• Severe hepatic, renal or cardiac failure (see section 4.4 Special warnings and precautions for use). 
• Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs. 
• Ischemic heart disease
• Peripheral arterial disease
• Cerebrovascular disease 
• Congestive heart failure (New York Heart Association [NYHA] classification II – IV

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 Posology and Method of administration and GI and cardiovascular risks below).</p><p>The concomitant use of Annuva with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see also section 4.2 Posology and Method of administration).</p><p>As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur in rare cases with diclofenac without earlier exposure to the drug (see section 4.8 Undesirable effects).</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection due to its pharmacodynamic properties.</p><p><strong>Gastrointestinal effects: </strong></p><p>Gastrointestinal bleeding (haematemesismelaena), ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac and may occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving Annuva, the drug should be withdrawn.</p><p>As with all NSAIDs, including diclofenac close medical surveillance is imperative and particular caution should be excised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable effects). The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac, and in patients with a history of ulcer, particularly if complicated with hemorrhage or perforation.</p><p>The elderly have increased frequency of adverse reactions to NSAIDs especially gastro-intestinal bleeding and perforation which may be fatal (see section 4.2 Posology and Method of administration).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with hemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal products likely to increase gastrointestinal risk (see section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding).</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other medicaments and other forms of interaction).</p><p>Close medical surveillance and caution should be exercised in patients with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8 Undesirable effects).</p><p><strong>Hepatic effects</strong>:</p><p>Close medical surveillance is required when prescribing diclofenac to patients with impairment of hepatic function as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure.</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), Annuva should be discontinued.</p><p>Hepatitis may occur with diclofenac without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p>In post marketing reports, cases of drug-induced hepatotoxicity have been reported in the first month, and in some cases, but can occur at any time during treatment with diclofenac. Post marketing surveillance has reported cases of severe hepatic reactions, including liver necrosis, jaundice, hepatitis with and without jaundice, and liver failure. Some of these reported cases resulted in fatalities or liver transplantation.</p><p>Physicians should measure liver enzymes especially transaminases periodically in patients receiving long-term therapy with diclofenac during week 4 &ndash; 8 from starting of treatment.</p><p><strong>Renal effects: </strong></p><p>As fluid retention and edema have been reported in association with NSAIDs therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the pre-treatment state.</p><p><strong>Skin effects:</strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Annuva (see section 4.8 Undesirable effects). Patients appear to be at the highest risk of these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Annuvashould be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.</p><p><strong>SLE and mixed connective tissue disease: </strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects).</p><p><strong>Cardiovascular and cerebrovascular effects:</strong></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and edema have been reported in association with NSAID therapy including diclofenac.</p><p>Clinical trial and epidemiological data suggest that use of diclofenac, particularly at high dose (150mg daily) and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke)<em>.</em></p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with diclofenac after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, and smoking).</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&rsquo;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>&nbsp;</p><p>NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.</p><p>All dosage forms of Diclofenac are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.</p><p>&nbsp;</p><p><strong>Hematological effects: </strong></p><p>Use of Annuva tablets is recommended only for short term treatment.</p><p>During prolonged treatment with Annuva, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>Annuva may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5 Interaction with other medicaments and other forms of interactions). Patients with defects of homeostasis, bleeding diathesis or hematological abnormalities should be carefully monitored.</p><p><strong>Pre-existing asthma: </strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&#39;soedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma.</p><p><strong>Female fertility: </strong></p><p>The use of Annuva may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Annuvashould be considered (see section 4.6 Pregnancy and lactation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with Annuva tablets and/or other pharmaceutical forms of diclofenac.</p><p><strong>Lithium:</strong> If used concomitantly, Annuva may increase plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p><strong>Digoxin:</strong> If used concomitantly, Annuva may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p><strong>Diuretics and antihypertensive agents: </strong>Like other NSAIDs, concomitant use of Annuva with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.</p><p>Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4 Special warnings and precautions for use).</p><p><strong>Anticoagulants and anti-platelet agents:</strong> Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and precautions for use). Although clinical investigations do not appear to indicate that Annuva has an influence on the effect of anticoagulants, there are isolated reports of an increased risk of hemorrhage in patients receiving diclofenac and anticoagulant concomitantly. (see section 4.4 Special warnings and precautions for use). Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required. As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation.</p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids:</strong> Co-administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs (see section 4.4 Special warnings and precautions for use).</p><p><strong>Antidiabetic</strong>: Clinical studies have shown that Annuvacan be given together with oral antidiabetic agents without influencing their clinical effect. However there have been isolated reports of hypoglycemic and hyperglycemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><strong>Methotrexate:</strong> Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are given within 24 hours of each other. This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p><strong>Ciclosporin: </strong>Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p><strong>Tacrolimus:</strong> Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p><p><strong>Quinolone antibacterialss</strong>: Convulsions may occur due to an interaction between quinolones and NSAIDs. This may occur in patients with or without a previous history of epilepsy or convulsions. Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><strong>Phenytoin:</strong> When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p><strong>Colestipol and cholestyramine:</strong> These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/cholestyramine.</p><p><strong>Cardiac glycosides:</strong> Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><strong>Mifepristone:</strong> NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p><strong>Potent CYP2C9 inhibitors:</strong> Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as sulfinpyrazone and voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Pregnancy category C in the first &amp; second trimester, Category X in the third trimester.</p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/fetal development. Data from epidemiological studies suggest an increased risk of miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1% up to approximately 1.5%.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during organogenetic period. If Annuvais used by a woman attempting to conceive, or during the 1st trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to:</p><p>- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension)</p><p>- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis</p><p>The mother and the neonate, at the end of the pregnancy, to:</p><p>- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses</p><p>- inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, Annuvais contraindicated during the third trimester of pregnancy.</p><p><strong>Lactation</strong></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore, diclofenac should not be administered during breast feeding in order to avoid undesirable effects in the infant.</p><p><strong>Female fertility</strong></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered.</p><p>See also section 4.4 Special warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, somnolence, central nervous system disturbances, drowsiness, or fatigue while taking NSAIDs should refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR">Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common ( 1/100, &lt;1/10); uncommon ( 1/1,000, &lt;1/100); rare ( 1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data.</p><p dir="LTR">The following undesirable effects include those reported with other short-term or long-term use.</p><p dir="LTR"><strong>Table 1</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:548px"><tbody><tr><td style="vertical-align:top"><p dir="LTR"><strong>Blood and lymphatic system disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Thrombocytopenia, leucopoenia, anemia (including hemolytic and aplastic anemia), agranulocytosis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Rare</p><p dir="LTR"><br /><br /><br /><br /><br /><br />Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p dir="LTR">Angioneuroticoedema (including face edema).</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p><p dir="LTR"><br /><br /><br /><br /><br /><br />Unknown</p></td><td style="vertical-align:top"><p dir="LTR">Headache, dizziness.</p><p dir="LTR">Somnolence, tiredness.</p><p dir="LTR">Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p dir="LTR">Confusion, hallucinations, disturbances of sensation, malaise</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Eye disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p><p dir="LTR">Unknown</p></td><td style="vertical-align:top"><p dir="LTR">Visual disturbance, vision blurred diplopia.</p><p dir="LTR">Optic neuritis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Ear and labyrinth disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Common</p><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Vertigo.</p><p dir="LTR">Tinnitus, hearing impaired.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Cardiac disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Palpitations, chest pain, cardiac failure, myocardial infarction.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Vascular disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Hypertension, hypotension, vasculitis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Asthma (including dyspnoea).</p><p dir="LTR">Pneumonitis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">&nbsp;</p><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p dir="LTR">Gastritis, gastrointestinal hemorrhage, haematemesis, diarrhea hemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p><p dir="LTR">Colitis (including hemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Transaminases increased.</p><p dir="LTR">Hepatitis, jaundice, liver disorder.</p><p dir="LTR">Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Rash.</p><p dir="LTR">Urticaria.</p><p dir="LTR">Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Rare</p></td><td style="vertical-align:top"><p dir="LTR">Edema</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR"><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Very rare</p></td><td style="vertical-align:top"><p dir="LTR">Impotence</p></td></tr></tbody></table><p dir="LTR">Clinical trial and epidemiological data suggest that use of diclofenac, particularly at high doses (150mg daily) and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4 Special warnings and special precautions for use)<em>. </em></p><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table><p><br /><strong>To report any side effect(s):</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p> The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting or convulsions. In the case of significant poisoning acute renal failure and liver damage are possible.</p><p><strong>Therapeutic measures</strong></p><p>Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to high protein binding and extensive metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR"><strong>Pharmacotherapeutic group</strong></p><p dir="LTR">Nonsteroidal anti-inflammatory drugs (NSAIDs).</p><p dir="LTR"><strong>Mechanism of action</strong></p><p dir="LTR">Annuva is a nonsteroidal agent with marked analgesic/anti- inflammatory properties. It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).</p><p dir="LTR">Diclofenac sodium <em>in vitro</em> does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings.</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR"><strong>Absorption</strong></p><p dir="LTR">Absorption begins immediately upon administration. Mean peak plasma concentrations of diclofenac are reached at about 1 hour 0.9 &plusmn; 0.4&micro;g/ml (1&micro;g/mL &equiv; 3&micro;mol/L). Ingestion of dispersible tablets together with or immediately after a meal does not delay the onset of absorption but reduces the amount absorbed by on average of about 16% and the maximum concentrations by about 50%.</p><p dir="LTR"><strong>Bioavailability</strong>:</p><p dir="LTR">The bioavailability is 82% of that of enteric-coated tablets. Ingestion with food affects the bioavailability (see above).</p><p dir="LTR">Pharmacokinetic behavior does not change on repeated administration. Accumulation does not occur, provided the recommended dosage intervals are observed.</p><p dir="LTR"><strong>Distribution</strong></p><p dir="LTR">The active substance is 99.7% protein bound, mainly to albumin (99.4%).</p><p dir="LTR">Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching the peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and they remain higher for up to 12 hours.</p><p dir="LTR"><strong>Metabolism</strong></p><p dir="LTR">Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites, most of which are converted to glucuronide conjugates. Two phenolic metabolites are biologically active, but to a much lesser extent than diclofenac.</p><p dir="LTR"><strong>Elimination</strong></p><p dir="LTR">The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours.</p><p dir="LTR">About 60% of the administered dose is excreted in the urine in the form of the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the feces.</p><p dir="LTR"><strong>Characteristics in patients</strong></p><p dir="LTR"><em>Elderly</em>: No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or excretion have been observed, other than the finding that in five elderly patients, a 15 minute iv infusion resulted in 50% higher plasma concentrations than expected with young healthy subjects.</p><p dir="LTR"><em>Patients with renal impairment: </em>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of &lt;10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile.</p><p dir="LTR"><em>Patients with hepatic disease: </em>In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:595px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">Lact/Cellul-Cellactose (Meggle)</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Kollidon CL BASF</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Colloidal Silicon Dioxide</p></td></tr><tr><td style="vertical-align:top"><p dir="LTR">Sodium Lauryl Sulphate</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">Not Applicable</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a dry place, below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td><td style="vertical-align:top"><p dir="LTR">Each pack contains 20 dispersible tablets</p><p dir="LTR">Clear PVC/PVDC Blister Strip and Aluminum Foil</p></td><td style="vertical-align:top"><p dir="LTR">&nbsp;</p></td></tr></tbody></table><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The dispersible tablets should be dissolved in water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation

For

Dammam Pharma



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2017.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>